Translating a Trillion Pointo Diseases of Data into Therapies
summary
Lab converts public genomic and clinical repositories into finished products: a hemopexin blood test for preeclampsia derived from meta-analysis of hundreds of microarray experiments, spun into Carmenta acquired in 24 months; a systematic drug‑repurposing pipeline that predicts candidates, validates in mice and runs a computationally driven lung cancer trial for $50,000; and a production 14 million‑patient UC electronic health record warehouse used to map disease trajectories and predict near‑term outcomes.
AI-written summary · about
chapters (8)
- 0:00The era of health data
- 1:14Growth of open data
- 5:32Leveraging public data
- 7:53Developing new diagnostics
- 11:26Accelerating drug discovery
- 13:46Garage biotech success
- 16:09The future of clinical data
- 17:31Predictive health mapping
related talks
53mThe Algorithm for Precision Medicine
50mThe algorithm for precision medicine
35mUsing Large-Scale Clinico-Genomics Data for in silico Clinical Trials and Precision Oncology
22mReimaging Healthcare
17mBig data in personalized medicine
11mEnsuring Reliability in Healthcare Data Engineering
34mFrom Data to Discovery: How AI Is Finding Hidden Cures
10mGenesis Final Round - Drylab AI